Skip to main content

BMY - Bristol-Myers Squibb Co

This page shows which of the focused investors we track hold BMY and how their positions changed, so you can see how much conviction the group has in the stock.

In Q1 2022 it was held by 11 managers with an aggregate reported value of $2.42B, which is 0.20% of the combined portfolio.

As of Q1 2022, 11 tracked institutional managers held BMY (Bristol-Myers Squibb Co) with an aggregate reported value of $2.42B0.20% of the combined AlphaBaseline portfolio.

Get email alerts when a tracked manager trades BMY sign in or create a free account.

Source
Curated SEC 13F filings
Period
Q1 2022
Ticker
BMY

13F data is delayed and excludes shorts/non-13F assets.

Holders

1Dodge & Cox - Dodge & Cox1.20%Reduce -1.3%27,003,359$1.97B
2Richard Pzena - Pzena Investment Management1.00%Add +213.7%3,625,787$264.79M
3Kahn Brothers Group - Kahn Brothers Group8.58%Add +0.5%925,728$67.61M
4Ariel Investments - Ariel Investments0.52%Add +0.7%795,902$58.13M
5Michael Burry - Scion Asset Management10.88%-300,000$21.91M
6Torray Funds - Torray Funds2.54%Reduce -0.1%216,771$15.83M
7Hillman Value Fund - Hillman Value Fund3.15%Add +1.3%135,731$9.91M
8Mairs & Power Growth Fund - Mairs & Power Growth Fund0.05%Reduce -2.4%68,771$5.02M
9Jensen Investment Management - Jensen Investment Management0.01%-26,375$1.93M
10David Katz - Matrix Asset Advisors0.07%Reduce -12.2%7,184$525K
11David Rolfe - Wedgewood Partners0.07%Add +48.1%6,925$505K
Loading holder history for BMY